Publication | Open Access
Involvement of CCR6/CCL20/IL-17 Axis in NSCLC Disease Progression
73
Citations
27
References
2011
Year
Our findings suggest that the CCL20/CCR6 axis promotes NSCLC disease progression. CCR6 is identified as a potential new prognostic marker and the CCL20/CCR6/IL-17 axis as a potential new therapeutic target. Larger scale studies are required to consolidate these observations.
| Year | Citations | |
|---|---|---|
Page 1
Page 1